Bringing the Oncology Community Together

Dr. Rugo on Metastatic Breast Cancer Guidelines

Hope S. Rugo, MD
Published Online: Friday, October 11, 2013
Hope S. Rugo, MD, professor of medicine and director of breast oncology and clinical trials education at the University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, discusses new guidelines for the treatment of patients with metastatic breast cancer.

The most important questions that need to be answered in this space concern treating based on biology, goals in therapy, and the use of hormone therapy, chemotherapy, and imaging. Currently, these issues are dealt with on an individual basis: between the patient and physician.

While it is nice to have guidelines from the Advanced Breast Cancer First International Consensus Conference, Rugo says, it is only the beginning.

At the Advanced Breast Cancer Second International Consensus Conference, which will take place in Lisbon, Portugal, from November 7-9, 2013, Rugo expects that significant progress will be made in incorporating new data into new guidelines.

Related Articles
Experts Debate Utility of Genomic Profiling in Daily Practice
Although the potential for next-generation sequencing of breast cancer tumors to improve treatment strategies is widely recognized, questions swirl about the optimal use of such increasingly available technologies in clinical practice for today’s patients.
Introduction: Breakthrough Pain in Patients With Cancer
Moderator, Jeffrey A. Gudin, MD, introduces a panel discussion focused on the management of breakthrough pain in patients with cancer. The conversation includes unique expert insight from Charles E. Argoff, MD, Jeri L. Ashley, RN, Vitaly Gordin, MD, and Marc Rappaport, DO.
AR Findings Highlight Detailed Tumor-Profiling Study
A wide-ranging analysis of more than 5500 breast cancer tumors that combined genomic and protein expression testing has identified promising targets to explore for treating patients with poor prognoses, with particularly notable findings involving androgen receptor (AR) expression
Most Popular Right Now
More Reading
External Resources

American Journal of Managed Care
HCPLive
PainLive
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
TargetedOnc
OncLive Resources

Archives
Blogs
OncLive TV
Oncology Nurses
Publications
Specialties
Web Exclusives


About Us
Advertise
Advisory Board
Contact Us
Forgot Password
Privacy Policy
Terms & Conditions
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright OncLive 2006-2014
Intellisphere, LLC. All Rights Reserved.